DB code: D00514
| RLCP classification | 1.15.30200.84 : Hydrolysis | |
|---|---|---|
| CATH domain | 3.40.50.1240 : Rossmann fold | Catalytic domain |
| 3.40.50.1240 : Rossmann fold | ||
| E.C. | 3.1.3.2 3.1.3.26 | |
| CSA | ||
| M-CSA | ||
| MACiE | ||
| CATH domain | Related DB codes (homologues) |
|---|---|
| 3.40.50.1240 : Rossmann fold | S00365 S00363 S00366 D00460 |
| Uniprot Enzyme Name | UniprotKB | Protein name | Synonyms | Includes | RefSeq | Pfam |
|---|---|---|---|---|---|
| P07102 |
Periplasmic appA protein
|
None |
Phosphoanhydride phosphohydrolase
EC 3.1.3.2 pH 2.5 acid phosphatase (AP) 4-phytase EC 3.1.3.26 |
NP_415500.1
(Protein)
NC_000913.2 (DNA/RNA sequence) YP_489251.1 (Protein) NC_007779.1 (DNA/RNA sequence) |
PF00328
(His_Phos_2)
[Graphical View] |
| KEGG enzyme name |
|---|
|
acid phosphatase
(EC 3.1.3.2 ) acid phosphomonoesterase (EC 3.1.3.2 ) phosphomonoesterase (EC 3.1.3.2 ) glycerophosphatase (EC 3.1.3.2 ) acid monophosphatase (EC 3.1.3.2 ) acid phosphohydrolase (EC 3.1.3.2 ) acid phosphomonoester hydrolase (EC 3.1.3.2 ) uteroferrin (EC 3.1.3.2 ) acid nucleoside diphosphate phosphatase (EC 3.1.3.2 ) orthophosphoric-monoester phosphohydrolase (acid optimum) (EC 3.1.3.2 ) 4-phytase (EC 3.1.3.26 ) 6-phytase (name based on 1L-numbering system and not 1D-numbering) (EC 3.1.3.26 ) phytase (EC 3.1.3.26 ) phytate 6-phosphatase (EC 3.1.3.26 ) myo-inositol-hexakisphosphate 6-phosphohydrolase (name based on1L-numbering system and not 1D-numbering) (EC 3.1.3.26 ) |
| UniprotKB: Accession Number | Entry name | Activity | Subunit | Subcellular location | Cofactor |
|---|---|---|---|---|---|
| P07102 | PPA_ECOLI | A phosphate monoester + H(2)O = an alcohol + phosphate. Myo-inositol hexakisphosphate + H(2)O = 1D- myo-inositol 1,2,3,5,6-pentakisphosphate + phosphate. | Monomer. | Periplasm. |
| KEGG Pathways | Map code | Pathways | E.C. |
|---|---|---|
| MAP00361 | gamma-Hexachlorocyclohexane degradation | 3.1.3.2 |
| MAP00562 | Inositol phosphate metabolism | 3.1.3.26 |
| MAP00740 | Riboflavin metabolism | 3.1.3.2 |
| Compound table | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Substrates | Products | Intermediates | ||||||||||
| KEGG-id | C01153 | C01204 | C00001 | C00069 | C04579 | C00009 | ||||||
| E.C. |
3.1.3.2
|
3.1.3.26
|
3.1.3.2
3.1.3.26 |
3.1.3.2
|
3.1.3.26
|
3.1.3.2
3.1.3.26 |
||||||
| Compound | Orthophosphoric monoester | myo-inositol hexakisphosphate | H2O | Alcohol | 1D-myo-inositol 1,2,3,4,5-pentakisphosphate | Orthophosphate | ||||||
| Type | carbohydrate,phosphate group/phosphate ion | carbohydrate,phosphate group/phosphate ion | H2O | carbohydrate | carbohydrate,phosphate group/phosphate ion | phosphate group/phosphate ion | ||||||
| ChEBI |
17401 17401 |
15377 15377 |
48405 48405 |
26078 26078 |
||||||||
| PubChem |
22247451 962 22247451 962 |
1004 22486802 1004 22486802 |
||||||||||
| 1dklA01 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dklB01 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkmA01 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dknA01 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkoA01 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Analogue:WO4 | ||
| 1dkpA01 |
|
|
|
|
|
Unbound | Bound:IHP | Unbound | Unbound | Unbound | ||
| 1dkqA01 |
|
|
|
|
|
Unbound | Bound:IHP | Unbound | Unbound | Unbound | ||
| 1dklA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dklB02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkmA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dknA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkoA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkpA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| 1dkqA02 |
|
|
|
|
|
Unbound | Unbound | Unbound | Unbound | Unbound | ||
| Reference for Active-site residues | ||
|---|---|---|
| resource | references | E.C. |
| literature [2],[3] | ||
| Active-site residues | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PDB | Catalytic residues | Cofactor-binding residues | Modified residues | Main-chain involved in catalysis | Comment | |||||
| 1dklA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers);HIS 17;ASP 304 | ||||
| 1dklB01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers);HIS 17;ASP 304 | ||||
| 1dkmA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers);HIS 17;ASP 304 | ||||
| 1dknA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers);HIS 17;ASP 304 | ||||
| 1dkoA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers);HIS 17;ASP 304 | ||||
| 1dkpA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers); ;ASP 304 | mutant H17A | |||
| 1dkqA01 |
|
|
|
|
|
ARG 16;ARG 20;ARG 92;HIS 303(Stabilizers); ;ASP 304 | mutant H17A | |||
| 1dklA02 |
|
|
|
|
|
|||||
| 1dklB02 |
|
|
|
|
|
|||||
| 1dkmA02 |
|
|
|
|
|
|||||
| 1dknA02 |
|
|
|
|
|
|||||
| 1dkoA02 |
|
|
|
|
|
|||||
| 1dkpA02 |
|
|
|
|
|
|||||
| 1dkqA02 |
|
|
|
|
|
|||||
| References for Catalytic Mechanism | ||
|---|---|---|
| References | Sections | No. of steps in catalysis |
|
[2]
|
Fig.2, Fig.3, p.141-142 | 3 |
|
[3]
|
Fig.4 | 2 |
|
[6]
|
p.111 | |
| References | |
|---|---|
| [1] | |
| Resource | |
| Comments | X-ray crystallography |
| Medline ID | |
| PubMed ID | 8407898 |
| Journal | J Biol Chem |
| Year | 1993 |
| Volume | 268 |
| Pages | 20744-6 |
| Authors | Lindqvist Y, Schneider G, Vihko P |
| Title | Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrate. |
| Related PDB | 1rpa |
| Related UniProtKB | |
| [2] | |
| Resource | |
| Comments | X-ray crystallography |
| Medline ID | |
| PubMed ID | 8168503 |
| Journal | Eur J Biochem |
| Year | 1994 |
| Volume | 221 |
| Pages | 139-142 |
| Authors | Lindqvist Y, Schneider G, Vihko P |
| Title |
Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. |
| Related PDB | 1rpt |
| Related UniProtKB | |
| [3] | |
| Resource | |
| Comments |
active site mutation, |
| Medline ID | |
| PubMed ID | 8132635 |
| Journal | J Biol Chem |
| Year | 1994 |
| Volume | 269 |
| Pages | 8971-8 |
| Authors | Ostanin K, Saeed A, Van Etten RL |
| Title | Heterologous expression of human prostatic acid phosphatase and site-directed mutagenesis of the enzyme active site. |
| Related PDB | |
| Related UniProtKB | |
| [4] | |
| Resource | |
| Comments | X-ray crystallography (2.9 Angstroms) |
| Medline ID | |
| PubMed ID | 9804805 |
| Journal | J Biol Chem |
| Year | 1998 |
| Volume | 273 |
| Pages | 30406-9 |
| Authors | LaCount MW, Handy G, Lebioda L |
| Title | Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphatase. |
| Related PDB | 2hpa |
| Related UniProtKB | |
| [5] | |
| Resource | |
| Comments | Improvement of catalytic efficiency by site-directed mutagenesis |
| Medline ID | |
| PubMed ID | 11051103 |
| Journal | Arch Biochem Biophys |
| Year | 2000 |
| Volume | 382 |
| Pages | 105-12 |
| Authors | Rodriguez E, Wood ZA, Karplus PA, Lei XG |
| Title | Site-directed mutagenesis improves catalytic efficiency and thermostability of Escherichia coli pH 2.5 acid phosphatase/phytase expressed in Pichia pastoris. |
| Related PDB | |
| Related UniProtKB | |
| [6] | |
| Resource | |
| Comments | X-ray crystallography (2.05 Angstroms) |
| Medline ID | 20122624 |
| PubMed ID | 10655611 |
| Journal | Nat Struct Biol |
| Year | 2000 |
| Volume | 7 |
| Pages | 108-13 |
| Authors | Lim D, Golovan S, Forsberg CW, Jia Z |
| Title | Crystal structures of Escherichia coli phytase and its complex with phytate. |
| Related PDB | 1dkl 1dkm 1dkn 1dko 1dkp 1dkq |
| Related UniProtKB | |
| [7] | |
| Resource | |
| Comments | X-ray crystallography (3.1 Angstroms) |
| Medline ID | |
| PubMed ID | 10639192 |
| Journal | Prostate |
| Year | 2000 |
| Volume | 42 |
| Pages | 211-8 |
| Authors | Jakob CG, Lewinski K, Kuciel R, Ostrowski W, Lebioda L |
| Title | Crystal structure of human prostatic acid phosphatase . |
| Related PDB | |
| Related UniProtKB | |
| Comments |
|---|
|
According to the literature [2] and [3], Moreover, (1) The positive charged groups lower the pKa of the nucelophilic histidine (His12), (2) These groups will orient the phosphate group in a proper position so that the nucleophilic attack at the phosphorous atom can take place while the phosphorous-oxygen bond is cleaved. |
| Created | Updated |
|---|---|
| 2002-08-01 | 2009-02-26 |